Andrew Wu

809 total citations
34 papers, 557 citations indexed

About

Andrew Wu is a scholar working on Molecular Biology, Genetics and Hematology. According to data from OpenAlex, Andrew Wu has authored 34 papers receiving a total of 557 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Genetics and 9 papers in Hematology. Recurrent topics in Andrew Wu's work include Chronic Myeloid Leukemia Treatments (9 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Neonatal Respiratory Health Research (4 papers). Andrew Wu is often cited by papers focused on Chronic Myeloid Leukemia Treatments (9 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Neonatal Respiratory Health Research (4 papers). Andrew Wu collaborates with scholars based in United States, Canada and Singapore. Andrew Wu's co-authors include Keith L. Duncan, Neil C. Barman, Marian K. Rippy, Christopher K. Zarins, Hu Zhang, Irene Leung, M. Susana Levy, Gary J. Lye, Kwok‐Fai So and Kin Chiu and has published in prestigious journals such as Blood, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Andrew Wu

33 papers receiving 545 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrew Wu United States 12 192 149 78 64 60 34 557
Jordi Martorell Spain 12 172 0.9× 138 0.9× 114 1.5× 59 0.9× 92 1.5× 26 604
Yunshan Cao China 15 260 1.4× 201 1.3× 118 1.5× 49 0.8× 18 0.3× 87 726
Wojciech Ambrosius Poland 13 97 0.5× 59 0.4× 109 1.4× 51 0.8× 49 0.8× 28 541
S. Pavlović Serbia 18 115 0.6× 295 2.0× 51 0.7× 76 1.2× 55 0.9× 76 817
Kōji Abe Japan 14 96 0.5× 244 1.6× 54 0.7× 97 1.5× 31 0.5× 47 554
Sergio Solorio Mexico 13 51 0.3× 90 0.6× 75 1.0× 101 1.6× 33 0.6× 59 485
Wen Chen China 16 73 0.4× 64 0.4× 81 1.0× 200 3.1× 30 0.5× 73 755
Yoshihiko Saito Japan 8 150 0.8× 395 2.7× 83 1.1× 38 0.6× 31 0.5× 22 608

Countries citing papers authored by Andrew Wu

Since Specialization
Citations

This map shows the geographic impact of Andrew Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Wu more than expected).

Fields of papers citing papers by Andrew Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Wu. The network helps show where Andrew Wu may publish in the future.

Co-authorship network of co-authors of Andrew Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Wu. A scholar is included among the top collaborators of Andrew Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Wu. Andrew Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
3.
Wu, Andrew, et al.. (2024). Clinical Insights into Structure, Regulation, and Targeting of ABL Kinases in Human Leukemia. International Journal of Molecular Sciences. 25(6). 3307–3307. 3 indexed citations
4.
Wu, Andrew, Sarah Grasedieck, Hanyang Lin, et al.. (2023). Identification of multivariable microRNA and clinical biomarker panels to predict imatinib response in chronic myeloid leukemia at diagnosis. Leukemia. 37(12). 2426–2435. 6 indexed citations
5.
Wu, Andrew, et al.. (2023). The Hedgehog Pathway as a Therapeutic Target in Chronic Myeloid Leukemia. Pharmaceutics. 15(3). 958–958. 5 indexed citations
6.
Grasedieck, Sarah, Andrew Wu, Hanyang Lin, et al.. (2022). Identification of key microRNAs as predictive biomarkers of Nilotinib response in chronic myeloid leukemia: a sub-analysis of the ENESTxtnd clinical trial. Leukemia. 36(10). 2443–2452. 11 indexed citations
7.
Wu, Andrew, M Mukhtar-Yola, Caitlin Bakker, et al.. (2022). Innovations and adaptations in neonatal and pediatric respiratory care for resource constrained settings. Frontiers in Pediatrics. 10. 954975–954975. 3 indexed citations
8.
Wu, Andrew, et al.. (2022). 431: USING KAMISHIBAI CARDS TO PREVENT PEDIATRIC VENTILATOR-ASSOCIATED EVENTS: A SINGLE-CENTER STUDY. Critical Care Medicine. 51(1). 202–202. 1 indexed citations
9.
Wu, Andrew & Xiaoyan Jiang. (2021). p21-Activated kinases as promising therapeutic targets in hematological malignancies. Leukemia. 36(2). 315–326. 13 indexed citations
10.
Théret, Marine, Marcela Low, Lin Tung, et al.. (2021). In vitro assessment of anti-fibrotic drug activity does not predict in vivo efficacy in murine models of Duchenne muscular dystrophy. Life Sciences. 279. 119482–119482. 13 indexed citations
11.
Wu, Andrew, et al.. (2020). Inhibition of PAK6-Mediated Survival and Cell Cycle Controls Selectively Targets Therapy-Resistant CML Stem/Progenitor Cells. Blood. 136(Supplement 1). 5–6. 1 indexed citations
12.
Tran, Kiet A., et al.. (2020). A Low-Resource Oxygen Blender Prototype for Use in Modified Bubble CPAP Circuits. Journal of Medical Devices. 14(1). 7 indexed citations
13.
Wu, Andrew, et al.. (2017). Not all that vesicles is herpes. Diagnosis. 4(4). 261–264. 1 indexed citations
14.
Wu, Andrew, et al.. (2016). A case report of autoimmune necrotizing myositis presenting as dysphagia and neck swelling. PubMed. 16(1). 7–7. 9 indexed citations
15.
Jia, Cun-Xian, et al.. (2015). Association of the HTR2A 102T/C polymorphism with attempted suicide. Psychiatric Genetics. 25(4). 168–177. 14 indexed citations
16.
Wu, Andrew, Philip J. Budge, John V. Williams, et al.. (2015). Incidence and Risk Factors for Respiratory Syncytial Virus and Human Metapneumovirus Infections among Children in the Remote Highlands of Peru. PLoS ONE. 10(6). e0130233–e0130233. 23 indexed citations
17.
Chiu, Kin, et al.. (2011). Neurodegeneration of the retina in mouse models of Alzheimer’s disease: what can we learn from the retina?. AGE. 34(3). 633–649. 84 indexed citations
18.
Rippy, Marian K., et al.. (2011). Catheter-based renal sympathetic denervation: chronic preclinical evidence for renal artery safety. Clinical Research in Cardiology. 100(12). 1095–1101. 134 indexed citations
19.
Wu, Andrew, et al.. (2009). Microwell engineering characterization for mammalian cell culture process development. Biotechnology and Bioengineering. 105(2). 260–275. 68 indexed citations
20.
Wu, Andrew, S. K. Joshi, Wing C. Chan, et al.. (1995). Effects ofBCR-ABLAntisense Oligonucleotides (AS-ODN) on Human Chronic Myeloid Leukemic Cells: AS-ODN as Effective Purging Agents. Leukemia & lymphoma. 20(1-2). 67–76. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026